FDA Drug recall D-0857-2018
Lidocaine Patch 5% (700 mg) ,(NDC 0591-3525-11), 30 envelopes containing 1 patch each/ 30 Patches/Carton (NDC 0591-3525-30)
- FDA Drug
- Class III
- terminated
- Published 2018-05-30
On 2018-05-30 the FDA classified a Class III recall of Lidocaine Patch 5% (700 mg) ,(NDC 0591-3525-11), 30 envelopes containing 1 patch each/ 30 Patches/Carton (NDC 0591-3525-30) by Teva Pharmaceuticals Usa, citing failed Stability Specifications.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0857-2018 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2018-04-30 |
| Published | 2018-05-30 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Teva Pharmaceuticals Usa |
| Distribution | n/a |
Product
Lidocaine Patch 5% (700 mg) ,(NDC 0591-3525-11), 30 envelopes containing 1 patch each/ 30 Patches/Carton (NDC 0591-3525-30)
Reason
Failed Stability Specifications
Identifiers
| ndc | 0591-3525-11 |
|---|---|
| ndc | 0591-3525-30 |
| code_info | Carton Lot Number:1147020B Patch (Envelope) Lot Number: 1147020 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0857-2018%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.